logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Matsuda, Masaru
    Born in March 1970
    Individual (1 offspring)
    Officer
    icon of calendar 2023-12-06 ~ now
    OF - Director → CIF 0
  • 2
    Vairavan, Latha
    Born in August 1977
    Individual (1 offspring)
    Officer
    icon of calendar 2025-06-13 ~ now
    OF - Director → CIF 0
  • 3
    Burnett, Patrick
    Born in May 1971
    Individual (1 offspring)
    Officer
    icon of calendar 2022-09-09 ~ now
    OF - Director → CIF 0
  • 4
    icon of address3411 Silverside Road, 19810, 3411 Silverside Road, Tatnall Building #104, Wilmington, Delaware, United States
    Corporate (1 offspring)
    Person with significant control
    icon of calendar 2022-09-09 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 14
  • 1
    Topper, David Joseph
    Chief Financial Officer born in June 1957
    Individual
    Officer
    icon of calendar 2024-09-30 ~ 2025-05-06
    OF - Director → CIF 0
  • 2
    Moore, Matthew
    Chief Business Officer born in October 1972
    Individual
    Officer
    icon of calendar 2022-09-09 ~ 2024-05-15
    OF - Director → CIF 0
  • 3
    Blackbourn, David John, Professor
    University Professor born in October 1964
    Individual (1 offspring)
    Officer
    icon of calendar 2015-07-09 ~ 2022-09-09
    OF - Director → CIF 0
  • 4
    Huxley, Philip, Dr
    R&D born in November 1956
    Individual (2 offsprings)
    Officer
    icon of calendar 2014-11-12 ~ 2022-09-09
    OF - Director → CIF 0
    Huxley, Philip, Dr
    Individual (2 offsprings)
    Officer
    icon of calendar 2015-05-02 ~ 2022-09-09
    OF - Secretary → CIF 0
    Dr Philip Huxley
    Born in November 1956
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2022-09-09
    PE - Has significant influence or controlCIF 0
  • 5
    Watt, Alan Paul, Dr
    Cso born in September 1963
    Individual (9 offsprings)
    Officer
    icon of calendar 2021-08-06 ~ 2022-09-09
    OF - Director → CIF 0
  • 6
    Robison, Jessica Lynn
    Vice President born in August 1982
    Individual
    Officer
    icon of calendar 2023-12-06 ~ 2024-08-21
    OF - Director → CIF 0
  • 7
    Burrows, Scott Loren
    Chief Financial Officer born in March 1977
    Individual (1 offspring)
    Officer
    icon of calendar 2022-09-09 ~ 2023-08-31
    OF - Director → CIF 0
  • 8
    Lenoble, Philippe
    Investor born in November 1971
    Individual
    Officer
    icon of calendar 2019-06-12 ~ 2022-09-09
    OF - Director → CIF 0
  • 9
    Morris, Toby
    Individual
    Officer
    icon of calendar 2014-11-12 ~ 2015-05-01
    OF - Secretary → CIF 0
  • 10
    Holbrook, David Mark Anthony, Dr
    Head Of Seed Funds At Lifearc born in May 1960
    Individual (6 offsprings)
    Officer
    icon of calendar 2019-06-12 ~ 2021-04-28
    OF - Director → CIF 0
    Dr David Mark Anthony Holbrook
    Born in May 1960
    Individual (6 offsprings)
    Person with significant control
    icon of calendar 2019-06-14 ~ 2021-04-28
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firmCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% as a member of a firmCIF 0
  • 11
    Ashfield, Rebecca, Dr
    Research Scientist born in January 1967
    Individual
    Officer
    icon of calendar 2015-07-09 ~ 2022-09-09
    OF - Director → CIF 0
  • 12
    Terlouw, Clare Elizabeth
    Head Of Ventures, Life Arc born in December 1973
    Individual (9 offsprings)
    Officer
    icon of calendar 2021-06-10 ~ 2022-09-09
    OF - Director → CIF 0
  • 13
    Mica, Andrea Giacomo
    Director At Oxford Technology Management born in January 1968
    Individual (5 offsprings)
    Officer
    icon of calendar 2019-06-12 ~ 2022-09-09
    OF - Director → CIF 0
  • 14
    icon of addressLynton House, 7-12 Tavistock Square, London, United Kingdom
    Corporate
    Person with significant control
    2019-08-06 ~ 2022-09-09
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

DUCENTIS BIOTHERAPEUTICS LTD.

Previous names
TRIPOS BIOPHARMA LTD. - 2015-07-06
DUCENTIS BIOTHERAPEUTICS LTD. - 2015-05-08
DEUCENTIS LIMITED - 2014-11-17
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
0 GBP2024-12-31
106,708 GBP2023-12-31
Cash at bank and in hand
0 GBP2024-12-31
4,017 GBP2023-12-31
Current Assets
0 GBP2024-12-31
110,725 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-7,912,036 GBP2024-12-31
-3,321,201 GBP2023-12-31
Net Current Assets/Liabilities
-7,912,036 GBP2024-12-31
-3,210,476 GBP2023-12-31
Equity
Called up share capital
975 GBP2024-12-31
975 GBP2023-12-31
975 GBP2022-10-31
Share premium
9,252,080 GBP2024-12-31
6,114,317 GBP2023-12-31
6,114,317 GBP2022-10-31
Other miscellaneous reserve
757,032 GBP2024-12-31
757,032 GBP2023-12-31
Retained earnings (accumulated losses)
-17,922,123 GBP2024-12-31
-10,082,800 GBP2023-12-31
-6,867,716 GBP2022-10-31
Equity
-7,912,036 GBP2024-12-31
-3,210,476 GBP2023-12-31
Profit/Loss
Retained earnings (accumulated losses)
-7,839,323 GBP2024-01-01 ~ 2024-12-31
-3,215,084 GBP2022-11-01 ~ 2023-12-31
Profit/Loss
-7,839,323 GBP2024-01-01 ~ 2024-12-31
-3,215,084 GBP2022-11-01 ~ 2023-12-31
Issue of Equity Instruments
Called up share capital
0 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
3,137,763 GBP2024-01-01 ~ 2024-12-31
Average Number of Employees
32024-01-01 ~ 2024-12-31
Other Debtors
Amounts falling due within one year
0 GBP2024-12-31
106,708 GBP2023-12-31
Trade Creditors/Trade Payables
Current
0 GBP2024-12-31
872 GBP2023-12-31
Other Taxation & Social Security Payable
Current
0 GBP2024-12-31
82,613 GBP2023-12-31
Other Creditors
Current
7,912,036 GBP2024-12-31
3,237,716 GBP2023-12-31
Creditors
Current
7,912,036 GBP2024-12-31
3,321,201 GBP2023-12-31
Equity
Called up share capital
975 GBP2024-12-31
975 GBP2023-12-31

  • DUCENTIS BIOTHERAPEUTICS LTD.
    Info
    TRIPOS BIOPHARMA LTD. - 2015-07-06
    DUCENTIS BIOTHERAPEUTICS LTD. - 2015-07-06
    DEUCENTIS LIMITED - 2015-07-06
    Registered number 09307415
    icon of addressSuite 2 First Floor, 10 Temple Back, Bristol BS1 6FL
    PRIVATE LIMITED COMPANY incorporated on 2014-11-12 (11 years). The company status is Active.
    The last date of confirmation statement was made at 2025-02-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.